MiMedx Group Inc. (NASDAQ:MDXG) has a beta value of 1.67 and has seen 0.63 million shares traded in the last trading session. The company, currently valued at $1.68B, closed the last trade at $15.56 per share which meant it gained $0.51 on the day or 3.39% during that session. The MDXG stock price is 1.22% off its 52-week high price of $15.37 and 65.81% above the 52-week low of $5.32. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.57 million shares traded. The 3-month trading volume is 828.34K shares.
The consensus among analysts is that MiMedx Group Inc. (MDXG) is a Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.07.
MiMedx Group Inc. (NASDAQ:MDXG) trade information
Sporting 3.39% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 09/03/21 when the MDXG stock price touched $15.56 or saw a rise of 0.83%. Year-to-date, MiMedx Group Inc. shares have moved 71.37%, while the 5-day performance has seen it change 10.35%. Over the past 30 days, the shares of MiMedx Group Inc. (NASDAQ:MDXG) have changed 26.20%. Short interest in the company has seen 5.85 million shares shorted with days to cover at 11.38.
Wall Street analysts have a consensus price target for the stock at $20.00, which means that the shares’ value could jump 22.2% from current levels. The projected low price target is $17.00 while the price target rests at a high of $23.00. In that case, then, we find that the current price level is -47.81% off the targeted high while a plunge would see the stock gain -9.25% from current levels.
MiMedx Group Inc. (MDXG) estimates and forecasts
Figures show that MiMedx Group Inc. shares have outperformed across the wider relevant industry. The company’s shares have gained 56.85% over the past 6 months, with this year growth rate of 63.64%, compared to 7.50% for the industry. Revenue growth from the last financial year stood is estimated to be 1.00%.
3 analysts offering their estimates for the company have set an average revenue estimate of $58.77 million for the current quarter. 3 have an estimated revenue figure of $60.26 million for the next quarter concluding in Sep 2021.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -37.80% over the past 5 years. Earnings growth for 2021 is a modest -221.80% while over the next 5 years, the company’s earnings are expected to increase by 15.00%.
MiMedx Group Inc. is expected to release its next earnings report between November 02 and November 08 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
MiMedx Group Inc. (NASDAQ:MDXG)’s Major holders
Insiders own 4.33% of the company shares, while shares held by institutions stand at 50.54% with a share float percentage of 52.83%. Investors are also buoyed by the number of investors in a company, with MiMedx Group Inc. having a total of 130 institutions that hold shares in the company. The top two institutional holders are Essex Woodlands Management Inc. with over 23.38 million shares worth more than $240.78 million. As of Mar 30, 2021, Essex Woodlands Management Inc. held 21.20% of shares outstanding.
The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 4.12 million shares as of Mar 30, 2021. The firm’s total holdings are worth over $42.45 million and represent 3.74% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Mar 30, 2021, the former fund manager holds about 2.27% shares in the company for having 2.5 million shares of worth $25.76 million while later fund manager owns 1.42 million shares of worth $14.63 million as of Mar 30, 2021, which makes it owner of about 1.29% of company’s outstanding stock.